Page Nct des essais cliniques
Clinical Trial Results:
A double-blind, 3-arm study on weight loss with combination of micronised fenofibrate 267 mg and metformin 1700 mg per day compared to metformin 1700 mg and placebo, at 6 months, in obese patients, Followed by A double-blind, 2-arm investigation of weight-loss maintance with same combination of micronised fenofibrate 267 mg and metformin 1700 mg compared to placebo, at 6 months, in the resporders.
| Summary | |
EudraCT number | 2004-001731-28 |
Trial protocol | FI |
Global completion date | 10 Feb 2006 |
| Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
| Results information | |
Results version number | v1(current) |
This version publication date | 18 Dec 2019 |
First version publication date | 18 Dec 2019 |
Other versions | |
Summary report(s) | C LF 23-0121 04 01 - Version 2.0 - Synopsis_Redacted |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.